Literature DB >> 15777614

Different effects of surfactant and inhaled nitric oxide in modulation of inflammatory injury in ventilated piglet lungs.

Yourong Zhu1, Chunbao Guo, Lei Cao, Xiaohui Gong, Chuanqing Wang, Bo Sun.   

Abstract

Septic acute lung injury (ALI) causes high morbidity and mortality in intensive care service as a result of biotrauma and dysfunction in the lungs and other organ systems. We hypothesized that surfactant and/or inhaled nitric oxide (iNO) may have different effects in modulation of inflammatory injury in septic ALI. Twenty-four healthy, 6-9 kg piglets were anesthetized, and intraperitoneally injected with Escherichia coli, followed by a low tidal volume ventilation until sepsis and ALI developed within 4-6 h. They were then randomly treated in groups (n=6 each) as: control (C), inhaled NO at 10 ppm (NO), surfactant at 100mg/kg (Surf), or both surfactant and iNO (SNO). A normal control group (N) was sham-injected and similarly ventilated. Over the 24 h of treatment period, both Surf, and SNO groups had significantly improved PaO2/FiO2, dynamic compliance and resistance of respiratory system. At 24h, the best alveolar aeration and least protein leakage, the lowest wet-to-dry lung weight ratio and lung injury score were found in SNO. Activity of nuclear factor kappa B (NF-kappaB) and myeloperoxidase, interleukin 8 mRNA expression and melondialdehyde were significantly increased, and IL-10 mRNA decreased, in lung tissue of the C group, but were significantly altered in the SNO group, and moderately altered in either NO or Surf group. We conclude that the effects of lung protection by surfactant and/or iNO in this model may be different in modulation of inflammatory cytokine mRNA expression and activity of NF-kappaB, and iNO did not have adverse effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777614     DOI: 10.1016/j.pupt.2005.01.005

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  5 in total

1.  Inhaled NO contributes to lung repair in piglets with acute respiratory distress syndrome via increasing circulating endothelial progenitor cells.

Authors:  Yuanyuan Qi; Liling Qian; Bo Sun; Lijuan Liu; Panpan Wu; Libo Sun
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

2.  An Unsettled Promise: The Newborn Piglet Model of Neonatal Acute Respiratory Distress Syndrome (NARDS). Physiologic Data and Systematic Review.

Authors:  Dietmar Spengler; Nele Rintz; Martin F Krause
Journal:  Front Physiol       Date:  2019-10-30       Impact factor: 4.566

Review 3.  The Controversy Persists: Is There a Qualification Criterion to Utilize Inhaled Nitric Oxide in Pre-term Newborns?

Authors:  Frederico Vieira; Marjorie Makoni; Edgardo Szyld; Krishnamurthy Sekar
Journal:  Front Pediatr       Date:  2021-03-31       Impact factor: 3.418

Review 4.  New Pharmacologic Approaches to Bronchopulmonary Dysplasia.

Authors:  Katelyn Roberts; Gretchen Stepanovich; Varsha Bhatt-Mehta; Steven M Donn
Journal:  J Exp Pharmacol       Date:  2021-03-25

5.  Aerosolised surfactant generated by a novel noninvasive apparatus reduced acute lung injury in rats.

Authors:  Yu Sun; Rui Yang; Ji-gen Zhong; Feng Fang; Jin-jin Jiang; Ming-yao Liu; Jian Lu
Journal:  Crit Care       Date:  2009-03-04       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.